Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Solvent Selection and Preparation for Nanoparticle Synthesis

Posted on By

SOP for Solvent Selection and Preparation for Nanoparticle Synthesis

Standard Operating Procedure for Solvent Selection and Preparation for Nanoparticles

1) Purpose

This SOP provides a detailed guideline for selecting, handling, and preparing solvents used in the synthesis of nanoparticle formulations. This ensures the correct solvent is chosen for the desired nanoparticle properties and that solvents are handled safely.

2) Scope

This SOP applies to all staff involved in the preparation, selection, and handling of solvents for nanoparticle synthesis.

3) Responsibilities

  • Operators: Ensure the correct solvent is chosen, prepared, and handled according to this SOP.
  • QA: Verify that solvent handling procedures are compliant with safety and quality standards.
See also  SOP for Preparation of Carbon-Based Nanomaterials

4) Procedure

4.1 Solvent Selection

4.1.1 Criteria for Solvent Selection

  • 4.1.1.1 The solvent should be chosen based on the chemical properties of the precursor materials and the required characteristics of the nanoparticle product (e.g., size, stability).
  • 4.1.1.2 Choose solvents with high purity and low volatility unless otherwise specified for specific nanoparticle synthesis processes.

4.2 Solvent Preparation

4.2.1 Solvent Handling

  • 4.2.1.1 Always handle solvents in a fume hood or well-ventilated area to minimize exposure to fumes.
  • 4.2.1.2 Ensure all containers are properly labeled with the solvent name, concentration, and preparation date.

4.2.2 Solvent Dispensing

  • 4.2.2.1 Dispense the required amount of solvent using calibrated equipment (e.g., pipettes or volumetric flasks) to ensure accuracy in
formulation.
  • 4.2.2.2 Avoid spillage by using appropriate funnels and sealed containers during solvent transfer.
  • 5) Abbreviations, if any

    • PPE: Personal Protective Equipment
    • QA: Quality Assurance

    6) Documents, if any

    • Solvent Preparation Logbook

    7) References, if any

    • MSDS for solvents

    8) SOP Version

    Version 1.0

    Annexure

    Solvent Preparation Logbook Template

    Date Solvent Name Concentration Volume Prepared Operator Initials QA Initials
    DD/MM/YYYY Solvent Name Concentration % Volume in mL Operator Name QA Name
               
    See also  SOP for Preparation of Nanoparticles with Controlled Release Properties
    Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

    Post navigation

    Previous Post: SOP for Incorporation of Taste-Masking Agents in Nasal Sprays
    Next Post: SOP for Formulating Nasal Sprays for Allergic Rhinitis

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version